Literature DB >> 34340981

Correspondence on "SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response" by Bonelli et al.

Sarah H Chung1, Mark Wener2,3, Alison M Bays2, Habib Rahbar4, Chihiro Morishima3, Andrew B Bryan3, Susan L Fink3, Seth Cohen5, Nandita S Mani5, Anu Chaudhary3, Gregory C Gardner2.   

Abstract

Entities:  

Keywords:  COVID-19; rituximab; vaccination

Year:  2021        PMID： 34340981     DOI： 10.1136/annrheumdis-2021-220957

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  3 in total

1. 

Authors:  Maxime Auroux; Benjamin Laurent; Baptiste Coste; Emmanuel Massy; Alexandre Mercier; Isabelle Durieu; Cyrille B Confavreux; Jean-Christophe Lega; Sabine Mainbourg; Fabienne Coury
Journal:  Rev Rhum Ed Fr       Date:  2022-07-08

2.  Serologic Response to Coronavirus Disease 2019 (COVID-19) Vaccination in Patients With Immune-Mediated Inflammatory Diseases: A Systematic Review and Meta-analysis.

Authors:  Atsushi Sakuraba; Alexander Luna; Dejan Micic
Journal:  Gastroenterology       Date:  2021-09-29       Impact factor: 22.682

3.  COVID-19 mRNA Vaccine in Patients With Lymphoid Malignancy or Anti-CD20 Antibody Therapy: A Systematic Review and Meta-Analysis.

Authors:  Yusuke Ito; Akira Honda; Mineo Kurokawa
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2022-03-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.